Edwards Lifesciences Corp (EW)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Edwards Lifesciences Corp (EW) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013582
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:35
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Edwards Lifesciences Corp (Edwards) is a global medical technology company, which focuses on the development, manufacture and marketing of products and technologies used for the treatment of structural heart disease and critical conditions. It develops and commercializes heart valve products such as tissue heart valves and repair products aimed for the replacement or repair of a patient’s diseased or defective heart valve. Edwards also offers hemodynamic monitoring systems, which are used for the measurement of a patient’s cardiovascular function in the hospital setting. Edwards sells its products through direct sales force and a network of independent distributors. The company operates in North America, Europe, Asia-Pacific and other regions. Edwards is headquartered in Irvine, California, the US.

Edwards Lifesciences Corp (EW) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Edwards Lifesciences Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Edwards Lifesciences Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Edwards Lifesciences Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Edwards Lifesciences Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Edwards Lifesciences Corp, Medical Devices Deals, 2011 to YTD 2017 9
Edwards Lifesciences Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Edwards Lifesciences Corp, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
V-Wave Raises USD28 Million in Venture Financing 11
Middle Peak Medical Raises US$11.5 Million In Series A Venture Financing 12
Debt Offering 14
Edwards Lifesciences Completes Public Offering Of Notes Due 2018 For US$600 Million 14
Edwards Lifesciences Corp – Key Competitors 16
Edwards Lifesciences Corp – Key Employees 17
Edwards Lifesciences Corp – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 21
Financial Announcements 21
Oct 24, 2017: Edwards Lifesciences Announces Third Quarter Results 21
Apr 25, 2017: Edwards Lifesciences Reports First Quarter Results 23
Feb 01, 2017: Edwards Lifesciences Reports Fourth Quarter Results 25
Oct 25, 2016: Edwards Lifesciences Reports Third Quarter Results 27
Jul 26, 2016: Edwards Lifesciences Reports Second Quarter Results 29
Feb 02, 2016: Edwards Lifesciences Reports Fourth Quarter Results 31
Corporate Communications 33
Jul 05, 2016: Leslie Heisz Appointed To Edwards Lifesciences Board Of Directors 33
Mar 17, 2016: Steven Loranger Appointed To Edwards Lifesciences Board Of Directors 34
Appendix 35
Methodology 35
About GlobalData 35
Contact Us 35
Disclaimer 35

List of Tables
Edwards Lifesciences Corp, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Edwards Lifesciences Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Edwards Lifesciences Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Edwards Lifesciences Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Edwards Lifesciences Corp, Deals By Therapy Area, 2011 to YTD 2017 8
Edwards Lifesciences Corp, Medical Devices Deals, 2011 to YTD 2017 9
Edwards Lifesciences Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
V-Wave Raises USD28 Million in Venture Financing 11
Middle Peak Medical Raises US$11.5 Million In Series A Venture Financing 12
Edwards Lifesciences Completes Public Offering Of Notes Due 2018 For US$600 Million 14
Edwards Lifesciences Corp, Key Competitors 16
Edwards Lifesciences Corp, Key Employees 17
Edwards Lifesciences Corp, Other Locations 18
Edwards Lifesciences Corp, Subsidiaries 18

★海外企業調査レポート[Edwards Lifesciences Corp (EW)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sterigenics International LLC:医療機器:M&Aディール及び事業提携情報
    Summary Sterigenics International LLC (SteriGenics), formerly Radiation Sterilizers Inc, a subsidiary of Gtcr Llc, is a medical device company that offers sterilization technologies such as gamma irradiation, electron beam and ethylene oxide. The company was formerly known as Radiation Sterilizers, …
  • ALTANA AG:戦略・SWOT・企業財務分析
    ALTANA AG - Strategy, SWOT and Corporate Finance Report Summary ALTANA AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Rockwell Medical Inc (RMTI)-製薬・医療分野:企業M&A・提携分析
    Summary Rockwell Medical Inc (Rockwell) is a bio pharmaceutical company focusing on the development, manufacture and distribution of products and services for the treatment of iron deficiency, secondary hyperparathyroidism; end-stage renal disease (ESRD) and chronic kidney disease. Its major product …
  • Adisseo France SAS:企業の戦略的SWOT分析
    Adisseo France SAS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Fusion Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Fusion Pharmaceuticals Inc (Fusion Pharmaceuticals) is a clinical-stage biopharmaceutical company which develops targeted alpha-particle radio therapeutics for the treatment of chemotherapy resistant cancers. Its pipeline product includes FPX-01, a radiolabeled antibody designed to internali …
  • Parmalat S.p.A.:企業の戦略・SWOT・財務情報
    Parmalat S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Parmalat S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Domtar Corp (UFS):企業の財務・戦略的SWOT分析
    Domtar Corp (UFS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • SK Biopharmaceuticals Co Ltd-製薬・医療分野:企業M&A・提携分析
    Summary SK Biopharmaceuticals Co Ltd (SK Biopharmaceuticals), a subsidiary of SK Holdings Co Ltd is a developer of drug candidates. The company develops and markets innovative drugs for the treatment of central nervous system. It offers plumiaz, SKL-N05 and JZP-110; YKP3089, relenopride, SKL-PD, SKL …
  • Zanders Paper GmbH:企業の戦略的SWOT分析
    Zanders Paper GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Crescendo Bioscience Inc-医療機器分野:企業M&A・提携分析
    Summary Crescendo Bioscience Inc (Crescendo), a subsidiary of Myriad Genetics Inc is a molecular diagnostics company that concentrates on rheumatology. The company develops quantitative, objective, and biology based tests for rheumatologists. Its vectra DA is an advanced blood test for rheumatoid ar …
  • Deere & Company:企業の戦略・SWOT・財務情報
    Deere & Company - Strategy, SWOT and Corporate Finance Report Summary Deere & Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Clinova Ltd:企業の戦略的SWOT分析
    Clinova Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Integra LifeSciences Holdings Corp (IART):企業の財務・戦略的SWOT分析
    Integra LifeSciences Holdings Corp (IART) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Hilton Worldwide Holdings Inc:戦略・SWOT・企業財務分析
    Hilton Worldwide Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary Hilton Worldwide Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Continental Engineering Corporation:企業の戦略・SWOT・財務情報
    Continental Engineering Corporation - Strategy, SWOT and Corporate Finance Report Summary Continental Engineering Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Aspial Corporation Ltd (A30):企業の財務・戦略的SWOT分析
    Aspial Corporation Ltd (A30) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Synaffix BV:製薬・医療:M&Aディール及び事業提携情報
    Summary Synaffix BV (Synaffix) is a biotechnology company that discovers and develops site-specific antibody-drug conjugates technology platforms. The company develops its products through its proprietary technology and GlycoConnect. It constructs homogenous and stable ADCs with the aid of a payload …
  • Msc Industrial Direct Co., Inc.
    Msc Industrial Direct Co., Inc. - Strategy, SWOT and Corporate Finance Report Summary Msc Industrial Direct Co., Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Compania Minera Antamina SA:企業の戦略・SWOT・財務情報
    Compania Minera Antamina SA - Strategy, SWOT and Corporate Finance Report Summary Compania Minera Antamina SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Personal Genome Diagnostics Inc:製品パイプライン分析
    Summary Personal Genome Diagnostics Inc (PGD) is a genomic solution provider. The company develops next-generation sequencing and proprietary algorithms to identify alterations in complex cancer genomes. It provides a portfolio of regulated tissue-based and liquid biopsy genomic products for laborat …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆